ConductScience.org, home

Paper15528343

Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection.

Jinushi M and 8 others. J Immunol, 2004. Cited by 165 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. Papers, record 15528343. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15528343

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection.
PubMed
Journal
J Immunol
PubMed
Year
2004
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
165
iCite
Relative citation ratio, by iCite
2.96
iCite
Revised in PubMed
2026-01-28
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jinushi MMasahisa
2Takehara TTetsuo
3Tatsumi TTomohide
4Kanto TTatsuya
5Miyagi TTakuya
6Suzuki TTakahiro
7Kanazawa YYoshiyuki
8Hiramatsu NNaoki
9Hayashi NNorio

Source PubMed

Topics29

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, CDMajor topic
Cytotoxicity, ImmunologicMajor topic
Dendritic CellsMajor topic
Down-RegulationMajor topic
Hepatitis C, ChronicMajor topic
Killer Cells, NaturalMajor topic
Lectins, C-TypeMajor topic
Receptors, ImmunologicMajor topic
Cell Differentiation
Cell Line, Tumor
Cell-Free System
Cells, Cultured
Coculture Techniques
HLA Antigens
Histocompatibility Antigens Class I
Humans
Immunophenotyping
Interleukin-10
K562 Cells
Lymphocyte Activation
Lymphocyte Count
NK Cell Lectin-Like Receptor Subfamily C
NK Cell Lectin-Like Receptor Subfamily D
Receptors, Natural Killer Cell
Signal Transduction
Suppressor Factors, Immunologic
Transforming Growth Factor beta
Up-Regulation
HLA-E Antigens

Source PubMed

Cited by106

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 165 citations.

PMIDTitleJournalYearIn PapersSource
42,666,682Hepatitis C virus-associated B-cell non-Hodgkin lymphomas: immune evasion, multistep lymphomagenesis, and candidate biomarkers for risk stratification and disease monitoring.Front Immunol2026https://conductscience.org/library/papers/42666682PubMed
41,583,436From innate-like to innate: the next wave of off-the-shelf CAR immunotherapies.Front Immunol2025https://conductscience.org/library/papers/41583436PubMed
40,453,084Recent advances in regulatory immune cells: exploring the world beyond Tregs.Front Immunol2025https://conductscience.org/library/papers/40453084PubMed
39,199,374The Role of Epigenetic Mechanisms in the Pathogenesis of Hepatitis C Infection.Biomolecules2024https://conductscience.org/library/papers/39199374PubMed
38,767,592NK-cell receptor modulation in viral infections.Clin Exp Immunol2024https://conductscience.org/library/papers/38767592PubMed
37,396,514Functional crosstalk and regulation of natural killer cells in tumor microenvironment: Significance and potential therapeutic strategies.Genes Dis2023https://conductscience.org/library/papers/37396514PubMed
37,371,767Non-Classical HLA Class 1b and Hepatocellular Carcinoma.Biomedicines2023https://conductscience.org/library/papers/37371767PubMed
37,119,279Protective and pathogenic functions of innate lymphoid cells in transplantation.Clin Exp Immunol2023https://conductscience.org/library/papers/37119279PubMed
36,936,055Natural killer cells in COVID-19: from infection, to vaccination and therapy.Future Virol2023https://conductscience.org/library/papers/36936055PubMed
36,311,746The liver-resident immune cell repertoire - A boon or a bane during machine perfusion?Front Immunol2022https://conductscience.org/library/papers/36311746PubMed
35,806,995NKG2A Expression among CD8 Cells Is Associated with COVID-19 Progression in Hypertensive Patients: Insights from the BRACE CORONA Randomized Trial.J Clin Med2022https://conductscience.org/library/papers/35806995PubMed
35,359,972Tissue-Dependent Adaptations and Functions of Innate Lymphoid Cells.Front Immunol2022https://conductscience.org/library/papers/35359972PubMed
35,267,563Innate and Adaptive Immunopathogeneses in Viral Hepatitis; Crucial Determinants of Hepatocellular Carcinoma.Cancers (Basel)2022https://conductscience.org/library/papers/35267563PubMed
35,053,151Role of IL-10-Producing Natural Killer Cells in the Regulatory Mechanisms of Inflammation during Systemic Infection.Biomolecules2021https://conductscience.org/library/papers/35053151PubMed
34,452,571The Putative Role of Natural Killer Cells in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma.Asian Pac J Cancer Prev2021https://conductscience.org/library/papers/34452571PubMed
34,230,995The role of natural killer cells in liver inflammation.Semin Immunopathol2021https://conductscience.org/library/papers/34230995PubMed
34,178,661CAR-NK Cell: A New Paradigm in Tumor Immunotherapy.Front Oncol2021https://conductscience.org/library/papers/34178661PubMed
34,062,821Natural Killer-Dendritic Cell Interactions in Liver Cancer: Implications for Immunotherapy.Cancers (Basel)2021https://conductscience.org/library/papers/34062821PubMed
34,054,844Characterization and Manipulation of the Crosstalk Between Dendritic and Natural Killer Cells Within the Tumor Microenvironment.Front Immunol2021https://conductscience.org/library/papers/34054844PubMed
33,859,642IL-10-Producing ILCs: Molecular Mechanisms and Disease Relevance.Front Immunol2021https://conductscience.org/library/papers/33859642PubMed

See all 106 cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
HLA-E3,133PubTator's text mininghttps://conductscience.org/library/genes/3133NCBI Gene
IL103,586PubTator's text mininghttps://conductscience.org/library/genes/3586NCBI Gene
KIR3DL13,811PubTator's text mininghttps://conductscience.org/library/genes/3811NCBI Gene
KLRC13,821PubTator's text mininghttps://conductscience.org/library/genes/3821NCBI Gene
KLRD13,824PubTator's text mininghttps://conductscience.org/library/genes/3824NCBI Gene
TGFB17,040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/15528343

GET https://conductscience.org/api/papers/v1/15528343/cited_by?page=2